Skip to content

Zymeworks ZYME Deferred Tax Assets

Deferred Tax Assets at other companies

Pfizer logo
PfizerPFE
-$12M-101%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$9.32M+75.4%
TG Therapeutics logo
TG TherapeuticsTGTX
$344.14M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$81.4M-24.1%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$72.83M+492%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$22.61M-23.0%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's deferred tax assets?
Zymeworks (ZYME) reported deferred tax assets of $3.83M in Q1 2026.
How has Zymeworks's deferred tax assets changed year-over-year?
Zymeworks's deferred tax assets decreased by 20.5% year-over-year, from $4.82M to $3.83M.
What is the long-term trend for Zymeworks's deferred tax assets?
Over 2 years (2023 to 2025), Zymeworks's deferred tax assets has grown at a 50.5% compound annual growth rate (CAGR), from $9.04M to $20.47M.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.